• Mobile vaccination van offering measles vaccines to refugees in Leicester

    It is part of a “wider" programme to “ensure the most vulnerable and marginalised" are protected against serious disease and illness

  • National Media Vaccine Network launched to boost vaccine uptake in Ghana

    In a concerted effort to combat misinformation and promote vaccine uptake across Ghana, the National Media Vaccine Network has been officially launched in Accra. Spearheaded by the Executive Secretary of the African Media and Malaria Network (AMMEREN), Dr Charity Binka, along with Dr Emmanuel Addipa-Adapoe and a dedicated team, this initiative marks a significant step […]

    • IAVI

    Participants in Nigeria vaccinated in first-ever Phase 2 Lassa fever vaccine clinical trial, sponsored by IAVI

    Key takeaways: Participants in Nigeria have been vaccinated with a Lassa

  • DOH expecting shortage on pertussis vaccines

    A shortage of pertussis or whooping cough vaccines is expected next month and an order for additional doses will be placed, according to the Department of Health.

  • Developing a vaccine for the 'zombie drug' xylazine

    Xylazine is an FDA-approved sedative and pain reliever for use in animals, but it has severe adverse effects when used in humans. It is now illicitly being added to opioids,

  • WHO Official Admits Vaccine Passports May Have Been A Scam

    WHO Official Admits Vaccine Passports May Have Been A Scam Authored by Paul D. Thacker via The Disinformation Chronicle (subscribe here), The World Health Organization’s Dr. Hanna Nohynek testified in court that she advised her government that vaccine passports were not needed but was ignored, despite explaining that the COVID vaccines did not stop virus transmission and the passports gave a false sense of security. The stunning revelations came to light in a Helsinki courtroom...

  • Chlamydia vaccine shows promise in early trial

    An early-stage clinical trial yielded promising results for a chlamydia vaccine, researchers reported Thursday in The Lancet Infectious Diseases. There is currently no vaccine to protect against the sexually transmitted infection, which is the most common bacterial STI in the United States, according to the Centers for Disease Control and Prevention. In 2022, there were more than 1.6 million cases. Chlamydia remains one of the most common causes of infertility in women, said Dr. Jay Varma,...

  • More cases of measles as MPs debate vaccination rate

    The number of cases of measles in the Netherlands this year has now reached 51, with the south of Brabant hardest hit, according to new figures from public health institute RIVM. In total, 43 cases have been reported in the region, with the rest elsewhere in Brabant and Limburg. In 2023 as a whole there were just seven cases of measles, and in 2022, six. The last major epidemic was in 2013 when almost 2,700 people were diagnosed with the disease

  • CDC finds no link between COVID vaccines and cardiac deaths

    The U.S. Centers for Disease Control and Prevention found no link between COVIDovid vaccines and cardiac deaths among young people.

  • OJ touted Covid vaccine as like wearing a seatbelt

    by WorldTribune Staff, April 11, 2024 OJ Simpson died at his Las Vegas home on Wednesday. He was 76. “On April 10th, our father, Orenthal James Simpson, succumbed to his battle with cancer,” his family announced on social media Thursday. “He was surrounded by his children and grandchildren.” Simpson had been battling prostate cancer. In […]

  • Health ministry did "reasonable job" sourcing Covid vaccines

    The health ministry acted quickly and in the public interest in its approach to buying coronavirus vaccines, the government’s audit office said in a new report on Wednesday. The report focuses on the way the first vaccines were sourced in 2020 and 2021, after the virus was identified in the Netherlands at the end of February 2020. The Netherlands eventually paid €1.8 billion for 102 million doses of vaccine from various suppliers, with Pfizer accounting for the bulk of them. Some 23

  • Everything you need to know about RSV and this vaccine known as Abrysvo

    Pfizer’s RSV vaccine also known as Abrysvo is showing the potential to protect adults ages 18 to 59 who are at high risk of getting sick.